TA172 Head and neck cancer (squamous cell carcinoma) - cetuximab: audit support

Audit support is developed to support the implementation of NICE guidance. The aim is to help NHS organisations with a baseline assessment and to assist with the audit process, thereby helping to ensure that practice is in line with the NICE recommendations. The audit support is based on the recommendations of the guidance.